Preclinical scientific tests suggest that retatrutide may perhaps influence obesity-linked most cancers development. Inside of a study led by Marathe et al., retatrutide-induced weight-loss minimized tumor engraftment, delayed tumor onset, and significantly attenuated tumor development in pancreatic and lung cancer versions, with increased tumor su